161 related articles for article (PubMed ID: 8092991)
1. Local pH-dependent conformational changes leading to proteolytic susceptibility of cystatin C.
Berti PJ; Storer AC
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):411-6. PubMed ID: 8092991
[TBL] [Abstract][Full Text] [Related]
2. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
3. Characterization by rapid-kinetic and equilibrium methods of the interaction between N-terminally truncated forms of chicken cystatin and the cysteine proteinases papain and actinidin.
Lindahl P; Nycander M; Ylinenjärvi K; Pol E; Björk I
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):165-71. PubMed ID: 1520264
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
[TBL] [Abstract][Full Text] [Related]
5. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
[TBL] [Abstract][Full Text] [Related]
6. Structure of chymopapain M the late-eluted chymopapain deduced by comparative modelling techniques and active-centre characteristics determined by pH-dependent kinetics of catalysis and reactions with time-dependent inhibitors: the Cys-25/His-159 ion-pair is insufficient for catalytic competence in both chymopapain M and papain.
Thomas MP; Topham CM; Kowlessur D; Mellor GW; Thomas EW; Whitford D; Brocklehurst K
Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):805-20. PubMed ID: 8010964
[TBL] [Abstract][Full Text] [Related]
7. Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin.
Lindahl P; Abrahamson M; Björk I
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):49-55. PubMed ID: 1731767
[TBL] [Abstract][Full Text] [Related]
8. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin.
Abrahamson M; Ritonja A; Brown MA; Grubb A; Machleidt W; Barrett AJ
J Biol Chem; 1987 Jul; 262(20):9688-94. PubMed ID: 3496337
[TBL] [Abstract][Full Text] [Related]
9. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.
Serveau C; Lalmanach G; Juliano MA; Scharfstein J; Juliano L; Gauthier F
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):951-6. PubMed ID: 8611180
[TBL] [Abstract][Full Text] [Related]
11. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
Björk I; Brieditis I; Abrahamson M
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of binding of chicken cystatin to papain.
Björk I; Alriksson E; Ylinenjärvi K
Biochemistry; 1989 Feb; 28(4):1568-73. PubMed ID: 2719920
[TBL] [Abstract][Full Text] [Related]
13. Papain labelled with fluorescent thiol-specific reagents as a probe for characterization of interactions between cysteine proteinases and their protein inhibitors by competitive titrations.
Lindahl P; Raub-Segall E; Olson ST; Björk I
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):387-94. PubMed ID: 2049069
[TBL] [Abstract][Full Text] [Related]
14. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
15. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
16. Differences in the effects of TFE on the folding pathways of human stefins A and B.
Zerovnik E; Virden R; Jerala R; Kroon-Zitko L; Turk V; Waltho JP
Proteins; 1999 Aug; 36(2):205-16. PubMed ID: 10398367
[TBL] [Abstract][Full Text] [Related]
17. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
18. Detailed biochemical characterization of human placental cystatin (HPC).
Rashid F; Sharma S; Bano B
Placenta; 2006 Aug; 27(8):822-31. PubMed ID: 16271758
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis and papain-catalysed hydrolysis of N-alpha-benzyloxycarbonyl-L-lysine p-nitroanilide.
Mackenzie NE; Malthouse JP; Scott AI
Biochem J; 1985 Mar; 226(2):601-6. PubMed ID: 3922354
[TBL] [Abstract][Full Text] [Related]
20. Expression of soluble form carp (Cyprinus carpio) ovarian cystatin in Escherichia coli and its purification.
Tzeng SS; Chen GH; Chung YC; Jiang ST
J Agric Food Chem; 2001 Sep; 49(9):4224-30. PubMed ID: 11559115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
